Akèy › Glomeruloskleroz fokal segmantè › New York
Etid klinik pou Glomeruloskleroz fokal segmantè nan New York
12 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #27, Valhalla
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- New York Nephrology and Dialysis Access Surgery, PC, Clifton Park
- NYU Langone Nephrology Associates-Mineola, Mineola
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Columbia University Irving Medical Center- Site Number : 8400001, New York
- The Children's Hospital at Montefiore- Site Number : 8400027, The Bronx
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Weill Cornell Medicine / NewYork-Presbyterian, New York
Ap rekrite
Jiska laj 75 · Tout sèks · Mizajou Aug 28, 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Weill Cornell Medical Center / NewYork-Presbyterian, New York
Ap rekrite
Jiska laj 21 · Tout sèks · Mizajou Aug 28, 2026 · NCT02235857NEPTUNE Match Study
- Northwell/Cohen's Children's Hospital, New Hyde Park
- Columbia University Medical Center, New York
Ap rekrite
Laj 1 a 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Cohen Children's Hospital, New Hyde Park
- New York University Medical Center, New York
- Bellevue Hospital, New York
- ak 3 plis
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cohen Children's Medical Center, New Hyde Park
Ap rekriteFaz 2
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
- Cohen Children's Medical Center, New Hyde Park
Ap rekrite
Laj 3 a 17 · Tout sèks · Mizajou Apr 17, 2026 · NCT05583942taVNS for FRNS in Children
- Cohen Children's Medical Center, New Hyde Park
Ap rekrite
Laj 3 a 17 · Tout sèks · Mizajou Apr 15, 2026 · NCT05588063AMPK-activation by Metformin in FSGS: AMP-FSGS
- Mount Sinai Hospital, New York
Ap rekriteFaz 1/2
Laj 18 a 80 · Tout sèks · Mizajou Feb 3, 2026 · NCT06090227A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Icahn School of Medicine at Mount Sinai, New York
Ap rekriteFaz 3
Laj 12 a 80 · Tout sèks · Mizajou Feb 3, 2026 · NCT05183646Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.